cyclohexanol has been researched along with Muscle Spasticity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DORELLO, U; SCORCIARINI-COPPOLA, A | 1 |
| Baker, D; Pryce, G | 1 |
2 other study(ies) available for cyclohexanol and Muscle Spasticity
| Article | Year |
|---|---|
[3,5,5-Trimethyl-cyclohexanol mandelic ester (cyclospasmol) in the treatment of spastic disorders of the retinal vessels].
Topics: Cardiovascular System; Cyclandelate; Cyclohexanols; Esters; Humans; Muscle Spasticity; Retina; Retinal Vessels | 1961 |
Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.
Topics: Animals; Benzoxazines; Body Temperature; Cross Reactions; Cyclohexanols; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Knockout; Morpholines; Multiple Sclerosis; Muscle Spasticity; Naphthalenes; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2007 |